Ceglédi, A.; Király, Á.; Várkonyi, A.; Tasnády, S.; Andrikovics, H.; Fekete, M.; Szabó, B.G.; Szemlaky, Z.; Szilágyi, Á.; Sinkovits, G.;
et al. Delayed Onset of Thrombotic Microangiopathy (TMA) upon Prolonged Carfilzomib Therapy in Multiple Myeloma: A Case Report and Comprehensive Review. Pharmaceuticals 2024, 17, 1722.
https://doi.org/10.3390/ph17121722
AMA Style
Ceglédi A, Király Á, Várkonyi A, Tasnády S, Andrikovics H, Fekete M, Szabó BG, Szemlaky Z, Szilágyi Á, Sinkovits G,
et al. Delayed Onset of Thrombotic Microangiopathy (TMA) upon Prolonged Carfilzomib Therapy in Multiple Myeloma: A Case Report and Comprehensive Review. Pharmaceuticals. 2024; 17(12):1722.
https://doi.org/10.3390/ph17121722
Chicago/Turabian Style
Ceglédi, Andrea, Ágnes Király, Andrea Várkonyi, Szabolcs Tasnády, Hajnalka Andrikovics, Mónika Fekete, Bálint G. Szabó, Zsuzsanna Szemlaky, Ágnes Szilágyi, György Sinkovits,
and et al. 2024. "Delayed Onset of Thrombotic Microangiopathy (TMA) upon Prolonged Carfilzomib Therapy in Multiple Myeloma: A Case Report and Comprehensive Review" Pharmaceuticals 17, no. 12: 1722.
https://doi.org/10.3390/ph17121722
APA Style
Ceglédi, A., Király, Á., Várkonyi, A., Tasnády, S., Andrikovics, H., Fekete, M., Szabó, B. G., Szemlaky, Z., Szilágyi, Á., Sinkovits, G., Prohászka, Z., Réti, M., & Mikala, G.
(2024). Delayed Onset of Thrombotic Microangiopathy (TMA) upon Prolonged Carfilzomib Therapy in Multiple Myeloma: A Case Report and Comprehensive Review. Pharmaceuticals, 17(12), 1722.
https://doi.org/10.3390/ph17121722
